The Enterprise Value as of December 2025 (TTM) for Anavex Life Sciences Corp. (0HFR.L) is 286.61M

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 286.61M. This represents a change of -52.92% compared to the average of 608.80M of the last 4 quarters.

Anavex Life Sciences Corp. (0HFR.L) Historical Enterprise Value (quarterly & annually)

How has 0HFR.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Anavex Life Sciences Corp. over the last ten years is 383.56M. The current 286.61M Enterprise Value has changed 7.37% with respect to the historical average. Over the past ten years (40 quarters), 0HFR.L's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the December 2018 quarter at 51.55M.

Anavex Life Sciences Corp. (0HFR.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anavex Life Sciences Corp. (0HFR.L) Average Enterprise Value

How has 0HFR.L Enterprise Value performed in the past?

The current Enterprise Value of Anavex Life Sciences Corp. (0HFR.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anavex Life Sciences Corp. (0HFR.L) Enterprise Value vs. Peers

How is 0HFR.L’s Enterprise Value compared to its peers?

Anavex Life Sciences Corp.’s Enterprise Value is less than Iovance Biotherapeutics, Inc. (686.90M), less than Verastem, Inc. (540.91M), less than Esperion Therapeutics, Inc. (831.55M), less than Emergent BioSolutions Inc. (1.06B), less than Geron Corporation (854.51M), less than Myriad Genetics, Inc. (739.16M), greater than Abeona Therapeutics Inc. (197.72M), less than OPKO Health, Inc. (986.25M), greater than Editas Medicine, Inc. (145.22M), less than Aclaris Therapeutics, Inc. (332.34M),

Build a custom stock screener for Anavex Life Sciences Corp. (0HFR.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (0HFR.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.